Farms.com Home   News

Pork Producers Warned of New Strain of Strep Zoo

The Canada West Swine Health Intelligence Network is warning pork producers of the risks posed by a new strain of Streptococcus zooepidemicus. The Canada West Swine Health Intelligence Network Swine Health Surveillance Report for the first quarter 2021 discusses a strain of Strep zoo first identified in 2019.

CWSHIN Manager Dr. Jette Christensen notes this strain has only been identified in five barns in Canada but it's also been identified in a couple of culled sow shipments going to the assembly yards or it's been detected when they arrive at the slaughter plants.

Clip-Dr. Jette Christensen-Canada West Swine Health Intelligence Network:

This particular strain of Streptococcus zooepidemicus can cause high mortalities in sows, 10 to 20 percent mortality, really noticeable so we're concerned about that. So far it seems that there's been only one clone but recently there's a new clone or a potential new strain surfaced in Indiana.

So, what is the take home message for our producers in Canada? The take home message is really that we're shipping animals to the U.S. and then vehicles come back and that's a risk.

It's a risk it's a risk for this new strain, it's a risk for other diseases such as PRRS coming back with these vehicles so we really need to make sure that our biosecurity, that our washing of these vehicles is good so we can avoid bringing something back with contaminated vehicles and equipment from the U.S. when we ship down there.

Source : Farmscape

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.